Literature DB >> 565830

Antibody against megakaryocytes in idiopathic thrombocytopenic purpura.

R McMillan, G A Luiken, R Levy, R Yelenosky, R L Longmire.   

Abstract

Purified human IgG from both serum and the culture of human splenic cells was radiolabeled with 125I. Incubation of radiolabeled IgG from patients with idiopathic thrombocytopenic purpura (ITP) with normal homologous platelets or bone marrow cells resulted in significant (P less than .001) binding when compared with control IgG. Radioautographs showed that the radioactivity was associated with the platelets or megakaryocytes. The antiplatelet antibody in ITP has specificity for antigens associated with both platelets and megakaryocytes and suggests that thrombopolesis may also be affected in this disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565830     DOI: 10.1001/jama.239.23.2460

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

Review 1.  The effect of antiplatelet autoantibodies on megakaryocytopoiesis.

Authors:  Robert McMillan; Diane Nugent
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 2.  Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.

Authors:  Cindy E Neunert; Melissa J Rose
Journal:  Blood Adv       Date:  2019-06-25

Review 3.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

4.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

5.  [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors:  Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal:  Wien Klin Wochenschr       Date:  2012-03-03       Impact factor: 1.704

6.  [Value of preoperative thrombocyte marking in patients with idiopathic thrombocytopenic purpura].

Authors:  M Gietz; W Mempel; C Clemm; E Hiller; M Heim; W Wilmanns
Journal:  Klin Wochenschr       Date:  1988-07-15

7.  Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.

Authors:  Donald M Arnold; Ishac Nazi; Lisa J Toltl; Catherine Ross; Nikola Ivetic; James W Smith; Yang Liu; John G Kelton
Journal:  Eur J Haematol       Date:  2015-03-13       Impact factor: 2.997

8.  Relative importance of total versus external platelet-associated IgG.

Authors:  U E Nydegger; J P Buchs; L Borradori
Journal:  Blut       Date:  1989-07

9.  Antigenic differences between human platelets and megakaryocytes.

Authors:  P Hyde; D Zucker-Franklin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

10.  Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.

Authors:  P J Ballem; G M Segal; J R Stratton; T Gernsheimer; J W Adamson; S J Slichter
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.